Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001711462-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-08 | 2026-01-07 | ANAB | Lizzul Paul F. | Chief Medical Off | S - Sale+OE | $45.11 | -2,235 | 37.2K | -6% | -$100.8K |
| D | 2026-01-08 | 2026-01-06 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | — | +6,145 | 39.4K | +18% | — |
| DM | 2026-01-08 | 2026-01-06 | ANAB | Lizzul Paul F. | Chief Medical Off | A - Grant | $0.00 | +50.4K | 21.4K | New | $0 |
| D | 2026-01-08 | 2026-01-06 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $0.00 | -6,145 | 6,145 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-07 | S | D | 2,235 | $45.11 | 37,213 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-06 | M | A | 6,145 | — | 39,448 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 3 | Derivative | Stock Option (right to buy) | 2026-01-06 | A | A | 29,000 | $0.00 | 29,000 | D | $43.91 · — to 2036-01-05 | 29,000 Common Stock | (F5) The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 4 | Derivative | Restricted Stock Unit | 2026-01-06 | A | A | 21,400 | $0.00 | 21,400 | D | — · — to — | 21,400 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F4) The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 5 | Derivative | Restricted Stock Unit | 2026-01-06 | M | D | 6,145 | $0.00 | 6,145 | D | — · — to — | 6,145 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F3) The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |